<!DOCTYPE html>

<!--
  Created : 1/19/2012 3:54:10 PM
  Author : Tom Coleman
  Copyright : 2011-2011
  By : University of Missippi Medical Center
-->

<html>
<head>
<title> Model </title>
<link rel='stylesheet' type='text/css' href='../../Style.CSS'>
</head>

<body>

<img src='../../SmallTitle.PNG'>
<img src='../DocsLightBlue.png'>
<a href='AldoTumor.html'><img src='../../Back.PNG'></a>
<p>AldoTumor.SecretionRate
<p>Overview
<p>Primary aldosteronism or "Conn's syndrome" occurs when a <br>small tumor of the zona glomerulosa cells develops and <br>secretes large amounts of aldosterone. The most important <br>effects are hypokalemia, a slight increase in extracellular <br>fluid volume and blood volume, a very slight increase in <br>plasma sodium concentration and hypertension. <br><br>Patients with primary aldosteronism often exhibit occasional <br>periods of muscle paralysis caused by hypokalemia. The <br>paralysis is caused by a depressant effect of low extracellular<br>potassium concentration on action potential transmission by <br>nerve fibers.<br><br>The model user can set secretion rates of an aldosterone <br>secreting tumor. Normal secretion rate of aldosterone <br>is 330.0 pMol/Min<br><br>JW Conn. Primary aldosteronism, a new clinical syndrome. <br>J Lab Clin Invest 45:3 - 17, 1955.<br><br>NM Kaplan. Primary aldosteronism with malignant hypertension.<br>New England Journal of Medicine 269:1282 - 1286, 1963.<br><br>RC Tarazi, MM ibrahim, EL Bravo, HP Dustan. Hemodynamic<br>characteristics of primary aldosteronism.<br>New England Journal of Medicine 289: 1330 -1335, 1973.

<p><img src='../../Footer.PNG'>

</body>
</html>
